Eradication therapy for Pseudomonas aeruginosa colonization episodes in cystic fibrosis patients not chronically colonized by P. aeruginosa

Journal of Cystic Fibrosis

Volumn 12, Issue 1, 2013, Pages 1-8

  Schelstraete, Petra ^a   Haerynck, Filomeen ^a   Van daele, Sabine ^a   Deseyne, Sarah ^a   De Baets, Frans ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cystic fibrosis; Eradication; Pseudomonas aeruginosa; Therapy

Indexed keywords

AZLOCILLIN; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANATE POTASSIUM PLUS TICARCILLIN; COLISTIN; IMIPENEM; TOBRAMYCIN;

AIRWAY; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CYSTIC FIBROSIS; ERADICATION THERAPY; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

CYSTIC FIBROSIS; HUMANS; PSEUDOMONAS INFECTIONS;

EID: 84870768231     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.07.008     Document Type: Review

References (40)

1. Cystic Fibrosis Foundation Patient Registry. Annual Data Report. 2010.
2. Burns J.L., Gibson R.L., McNamara S., Yim D., Emerson J., Rosenfeld M., et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001, 183(3):444-452.
3. Gibson R.L., Burns J.L., Ramsey B.W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003, 168(8):918-951.
4. Rosenfeld M., Ramsey B.W., Gibson R.L. Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management. Curr Opin Pulm Med 2003, 9(6):492-497.
5. Li Z., Kosorok M.R., Farrell P.M., Laxova A., West S.E., Green C.G., et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005, 293(5):581-588.
6. Johansen H.K., Hoiby N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 1992, 47(2):109-111.
7. Doring G., Conway S.P., Heijerman H.G., Hodson M.E., Hoiby N., Smyth A., et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000, 16(4):749-767.
8. Lee T.W., Brownlee K.G., Conway S.P., Denton M., Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003, 2(1):29-34.
9. Nixon G.M., Armstrong D.S., Carzino R., Carlin J.B., Olinsky A., Robertson C.F., et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001, 138(5):699-704.
10. Kerem E., Corey M., Gold R., Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 1990, 116(5):714-719.
11. Kosorok M.R., Zeng L., West S.E., Rock M.J., Splaingard M.L., Laxova A., et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001, 32(4):277-287.
12. Pamukcu A., Bush A., Buchdahl R. Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol 1995, 19(1):10-15.
13. Demko C.A., Byard P.J., Davis P.B. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995, 48(8):1041-1049.
14. Doring G., Hoiby N. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros 2004, 3(2):67-91.
15. Bendiak G.N., Ratjen F. The approach to Pseudomonas aeruginosa in cystic fibrosis. Semin Respir Crit Care Med 2009, 30(5):587-595.
16. Frederiksen B., Koch C., Hoiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999, 28(3):159-166.
17. Ballmann M., Rabsch P., von der Hardt H. Long-term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Thorax 1998, 53(9):732-737.
18. FitzSimmons S.C. The changing epidemiology of cystic fibrosis. J Pediatr 1993, 122(1):1-9.
19. Littlewood J.M., Miller M.G., Ghoneim A.T., Ramsden C.H. Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis. Lancet 1985, 1(8433):865.
20. Steinkamp G., Tummler B., Malottke R., von der Hardt H.. Treatment of pseudomonas aeruginosa colonisation in cystic fibrosis. Arch Dis Child 1989, 64(7):1022-1028.
21. Valerius N.H., Koch C., Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991, 338(8769):725-726.
22. Vazquez C., Municio M., Corera M., Gaztelurrutia L., Sojo A., Vitoria J.C. Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Acta Paediatr 1993, 82(3):308-309.
23. Wiesemann H.G., Steinkamp G., Ratjen G., Bauernfeind A., Przyklenk B., Doring G., et al. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Pediatr Pulmonol 1998, 25(2):88-92.
24. Ratjen F., Doring G., Nikolaizik W.H. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Lancet 2001, 358(9286):983-984.
25. Gibson R.L., Emerson J., McNamara S., Burns J.L., Rosenfeld M., Yunker A., et al. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med 2003, 167(6):841-849.
26. Gibson R.L., Emerson J., Mayer-Hamblett N., Burns J.L., McNamara S., Accurso F., et al. Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatr Pulmonol 2007, 42(7):610-623.
27. Taccetti G., Campana S., Festini F., Mascherini M., Doring G. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J 2005, 26(3):458-461.
28. Schelstraete P., Deschaght P., Van Simaey L., Van Daele S., Haerynck F., Vaneechoutte M., et al. Genotype based evaluation of Pseudomonas aeruginosa eradication treatment success in cystic fibrosis patients. J Cyst Fibros 2010, 9(2):99-103.
29. Munck A., Bonacorsi S., Mariani-Kurkdjian P., Lebourgeois M., Gerardin M., Brahimi N., et al. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatr Pulmonol 2001, 32(4):288-292.
30. Griese M., Muller I., Reinhardt D. Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis. Eur J Med Res 2002, 7(2):79-80.
31. Douglas T.A., Brennan S., Berry L., Winfield K., Wainwright C.E., Grimwood K., et al. Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis. Thorax 2010 Nov, 65(11):985-990.
32. Proesmans M., Vermeulen F., Boulanger L., Verhaegen J., De Boeck K. Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis. J Cyst Fibros 2012 Jul 2, [Electronic publication ahead of print].
33. Treggiari MM R.-B.G., Retsch-Bogart G., Mayer-Hamblett N., Khan U., Kulich M. Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Arch Pediatr Adolesc Med 2011, 165(9):847-856.
34. Ratjen F., Munck A., Kho P., Angyalosi G. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax 2010, 65(4):286-291. ELITE Study Group.
35. Mayer-Hamblett N., Kronmal R.A., Gibson R.L., Rosenfeld M., Retsch-Bogart G., Treggiari M.M., et al. Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis. Pediatr Pulmonol 2012, 47(2):125-134.
36. Taccetti G., Bianchini E., Cariani L., Buzzetti R., Costantini D., Trevisan F., et al. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. Thorax 2012 Feb 29, [Electronic publication ahead of print].
37. Frederiksen B., Koch C., Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997, 23(5):330-335.
38. Hansen C.R., Pressler T., Hoiby N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros 2008, 7(6):523-530.
39. McPherson H., Rosenthal M., Bush A. Can mucoid Pseudomonas aeruginosa be eradicated in children with cystic fibrosis?. Pediatr Pulmonol 2010, 45(6):566-568.
40. Troxler R.B., Hoover W.C., Britton L.J., Gerwin A.M., Rowe S.M. Clearance of initial mucoid Pseudomonas aeruginosa in patients with cystic fibrosis. Pediatr Pulmonol 2012 Apr 11, [Electronic publication ahead of print]. 10.1002/ppul.22543.